Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Real-world efficacy of first-line nivolumab plus ipilimumab and its practical predictive biomarkers in advanced renal cell carcinoma: First analysis from RENOIR study [KCSG GU22-13]open access
- Authors
- Kim, J. H.; Shin, S. J.; Bae, W. K.; Kim, S. H.; Kim, J. Y.; Im, H-S.; Kim, I-H.; Kim, I-H.; Park, K.; Kim, E.; Choi, M.; Lim, J. H.; Kim, H.; Kim, H-J.; Jo, J.; Lee, H. J.; Kim, D.; Sohn, B. S.; Park, I.; Park, J. H.
- Issue Date
- Sep-2024
- Publisher
- ELSEVIER
- Citation
- Annals of Oncology, v.35, no.S2, pp S1026 - S1026
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of Oncology
- Volume
- 35
- Number
- S2
- Start Page
- S1026
- End Page
- S1026
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Dal Yong
- Graduate School (Department of Medicine)